PL vs. CRVS
PL (Planet Labs PBC) and CRVS (Corvus Pharmaceuticals, Inc.) are both stocks. PL operates in Aerospace & Defense (Industrials), while CRVS operates in Biotechnology (Healthcare). Over the past 5 years, PL returned 25.63%/yr vs 33.63%/yr for CRVS. At a 0.27 correlation, their price movements are largely independent.
Performance
PL vs. CRVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PL achieves a 57.96% return, which is significantly higher than CRVS's 54.94% return.
PL
- 1D
- -8.84%
- 1M
- -23.54%
- YTD
- 57.96%
- 6M
- 70.78%
- 1Y
- 470.51%
- 3Y*
- 106.65%
- 5Y*
- 25.63%
- 10Y*
- —
CRVS
- 1D
- 2.84%
- 1M
- -24.68%
- YTD
- 54.94%
- 6M
- 42.53%
- 1Y
- 181.37%
- 3Y*
- 53.32%
- 5Y*
- 33.63%
- 10Y*
- 0.06%
PL vs. CRVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PL Planet Labs PBC | 57.96% | 388.12% | 63.56% | -43.22% | -29.27% | -37.24% |
CRVS Corvus Pharmaceuticals, Inc. | 54.94% | 43.93% | 203.98% | 107.06% | -64.73% | -14.23% |
Correlation
The correlation between PL and CRVS is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Apr 26, 2021 | 0.27 |
Fundamentals
PL:
$10.76B
CRVS:
$1.07B
PL:
-$1.17
CRVS:
-$0.53
PL:
24.26
CRVS:
4.46
PL:
$335.61M
CRVS:
$0.00
PL:
$186.28M
CRVS:
-$26.00K
PL:
-$125.70M
CRVS:
-$47.43M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PL vs. CRVS — Risk / Return Rank
PL
CRVS
PL vs. CRVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Planet Labs PBC (PL) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PL | CRVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.61 | ||
| Sortino ratioReturn per unit of downside risk | -0.08 | ||
| Omega ratioGain probability vs. loss probability | 1.55 | 1.48 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 11.79 | 3.23 | +8.56 |
| Martin ratioReturn relative to average drawdown | 36.80 | 7.03 | +29.77 |
Loading charts...
Drawdowns
PL vs. CRVS - Drawdown Comparison
The maximum PL drawdown since its inception was -85.73%, smaller than the maximum CRVS drawdown of -96.97%. Use the drawdown chart below to compare losses from any high point for PL and CRVS.
Loading charts...
Drawdown Indicators
| PL | CRVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.73% | -96.97% | +11.24% |
Max Drawdown (1Y)Largest decline over 1 year | -40.23% | -56.43% | +16.20% |
Max Drawdown (3Y)Largest decline over 3 years | -55.17% | -70.50% | +15.33% |
Max Drawdown (5Y)Largest decline over 5 years | -85.73% | -92.40% | +6.67% |
Max Drawdown (10Y)Largest decline over 10 years | — | -96.97% | — |
Current DrawdownCurrent decline from peak | -39.40% | -53.25% | +13.85% |
Average DrawdownAverage peak-to-trough decline | -49.90% | -69.28% | +19.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.88% | 25.91% | -13.03% |
Volatility
PL vs. CRVS - Volatility Comparison
Planet Labs PBC (PL) has a higher volatility of 39.48% compared to Corvus Pharmaceuticals, Inc. (CRVS) at 23.12%. This indicates that PL's price experiences larger fluctuations and is considered to be riskier than CRVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PL | CRVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 39.48% | 23.12% | +16.36% |
Volatility (6M)Calculated over the trailing 6-month period | 78.71% | 111.88% | -33.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 102.61% | 180.64% | -78.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.98% | 131.02% | -50.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.91% | 111.13% | -31.22% |
Dividends
PL vs. CRVS - Dividend Comparison
Neither PL nor CRVS has paid dividends to shareholders.
Financials
PL vs. CRVS - Financials Comparison
This section allows you to compare key financial metrics between Planet Labs PBC and Corvus Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PL and CRVS have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PL has higher volatility (39.48%) compared to CRVS (23.12%). In terms of maximum drawdown, PL dropped -85.73% vs CRVS's -96.97%.
PL currently has the higher Sharpe Ratio (4.62 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PL and CRVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer